Malpractice Litigation Related to Diagnosis and Treatment of Intracranial Aneurysms

References

1. 1.↵
   1. Malhotra A,
   2. Wu X,
   3. Forman HP, et al

   . Management of tiny unruptured intracranial aneurysms: a comparative effectiveness analysis. JAMA Neurol 2018;75:27–34 doi:10.1001/jamaneurol.2017.3232 pmid:29159405

   CrossRefPubMed
2. 2.↵
   1. Malhotra A,
   2. Wu X,
   3. Forman HP, et al

   . Growth and rupture risk of small unruptured intracranial aneurysms: a systematic review. Ann Intern Med 2017;167:26–33 doi:10.7326/M17-0246 pmid:28586893

   CrossRefPubMed
3. 3.↵
   1. Malhotra A,
   2. Wu X,
   3. Geng B, et al

   . Management of small unruptured intracranial aneurysms: a survey of neuroradiologists. AJNR Am J Neuroradiol 2018;39:875–80 doi:10.3174/ajnr.A5631 pmid:29650787

   Abstract/FREE Full Text
4. 4.↵
   1. Wu X,
   2. Matouk CC,
   3. Mangla R, et al

   . Cost-effectiveness of computed tomography angiography in management of tiny unruptured intracranial aneurysms in the United States. Stroke 2019;50:2396–403 doi:10.1161/STROKEAHA.119.025600 pmid:31340732

   CrossRefPubMed
5. 5.↵
   1. Malhotra A,
   2. Wu X,
   3. Forman HP, et al

   . Management of unruptured intracranial aneurysms in older adults: a cost-effectiveness analysis. Radiology 2019;291:411–17 doi:10.1148/radiol.2019182353 pmid:30888931

   CrossRefPubMed
6. 6.↵
   1. Malhotra A,
   2. Seifert K,
   3. Wu X, et al

   . Screening for intracranial aneurysms in patients with thoracic aortic aneurysms. Cerebrovasc Dis 2019;47:253–59 doi:10.1159/000501194 pmid:31412341

   CrossRefPubMed
7. 7.↵
   1. Malhotra A,
   2. Wu X,
   3. Matouk CC, et al

   . MR angiography screening and surveillance for intracranial aneurysms in autosomal dominant polycystic kidney disease: a cost-effectiveness analysis. Radiology 2019;291:400–08 doi:10.1148/radiol.2019181399 pmid:30777807

   CrossRefPubMed
8. 8.↵
   1. Wardlaw JM,
   2. White PM

   . The detection and management of unruptured intracranial aneurysms. Brain 2000;123:205–21 doi:10.1093/brain/123.2.205 pmid:10648430

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Gupta R,
   2. Griessenauer CJ,
   3. Moore JM, et al

   . An analysis of malpractice litigation related to the management of brain aneurysms. J Neurosurg 2017;127:1077–83 doi:10.3171/2016.9.JNS161124 pmid:28009242

   CrossRefPubMed
10. 10.↵
    1. Saint S,
    2. Vaughn VM,
    3. Chopra V, et al

    . Perception of resources spent on defensive medicine and history of being sued among hospitalists: results from a national survey. J Hosp Med 2018;13:26–29 doi:10.12788/jhm.2800 pmid:29068439

    CrossRefPubMed
11. 11.↵
    1. Nahed BV,
    2. Babu MA,
    3. Smith TR, et al

    . Malpractice liability and defensive medicine: a national survey of neurosurgeons. PLoS One 2012;7:e39237 doi:10.1371/journal.pone.0039237 pmid:22761745

    CrossRefPubMed
12. 12.↵
    1. Williams PL,
    2. Williams JP,
    3. Williams BR

    . The fine line of defensive medicine. J Forensic Leg Med 2021;80:102170 doi:10.1016/j.jflm.2021.102170 pmid:33878590

    CrossRefPubMed
13. 13.↵
    1. Haslett JJ,
    2. Genadry L,
    3. Zhang X, et al

    . Systematic review of malpractice litigation in the diagnosis and treatment of acute stroke. Stroke 2019;50:2858–64 doi:10.1161/STROKEAHA.119.025352 pmid:31422736

    CrossRefPubMed
14. 14.↵
    1. Malhotra A,
    2. Wu X,
    3. Kalra VB, et al

    . Cost-effectiveness analysis of follow-up strategies for thunderclap headache patients with negative noncontrast CT. Acad Emerg Med 2016;23:243–50 doi:10.1111/acem.12891 pmid:26728524

    CrossRefPubMed
15. 15.↵
    1. Wu X,
    2. Kalra VB,
    3. Forman HP, et al

    . Cost-effectiveness analysis of CTA and LP for evaluation of suspected SAH after negative non-contrast CT. Clin Neurol Neurosurg 2016;142:104–11 doi:10.1016/j.clineuro.2015.12.021 pmid:26827168

    CrossRefPubMed
16. 16.↵
    1. Malhotra A,
    2. Wu X,
    3. Gandhi D, et al

    . The patient with thunderclap headache. Neuroimaging Clin N Am 2018;28:335–51 doi:10.1016/j.nic.2018.03.002 pmid:30007749

    CrossRefPubMed
17. 17.↵
    1. Dubosh NM,
    2. Bellolio MF,
    3. Rabinstein AA, et al

    . Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Stroke 2016;47:750–55 doi:10.1161/STROKEAHA.115.011386 pmid:26797666

    Abstract/FREE Full Text
18. 18.↵
    1. Marasini A,
    2. Shrestha A,
    3. Phuyal S, et al

    . Role of artificial intelligence in unruptured intracranial aneurysm: an overview. Front Neurol 2022;13:784326 doi:10.3389/fneur.2022.784326 pmid:35280303

    CrossRefPubMed
19. 19.↵
    1. Mezrich JL

    . Is artificial intelligence (AI) a pipe dream? Why legal issues present significant hurdles to AI autonomy. AJR Am J Roentgenol 2022;219:152–56 doi:10.2214/AJR.21.27224 pmid:35138133

    CrossRefPubMed
20. 20.↵
    1. Jena AB,
    2. Seabury S,
    3. Lakdawalla D, et al

    . Malpractice risk according to physician specialty. N Engl J Med 2011;365:629–36 doi:10.1056/NEJMsa1012370 pmid:21848463

    CrossRefPubMedWeb of Science